+44 20 3868 9735
The liver is a key organ that performs many functions associated with metabolism, energy storage, and waste from the body. It assistances to digest food, translate it to energy and store the energy until necessary. Liver disease is a wideranging term that states to any condition disturbing the liver functions. These conditions may progress for different reasons but can all harm the liver and impacts its operations. In the Ayurvedic classics, Yakut (Liver) is a Moola Sthana of Ratktavaha Strotas. So, liver diseases come under the disorders of Raktavaha Strotas. Concerning the treatment part of Raktavaha Strotas Vikara, Virechana Karma has got prime importance.
Here we study Trivrutta Churna Nitya Virechana (Daily Purgation) effect in Yakrut Vikara (Liver Diseases) with abnormal liver function test.
In the present case study, the success story of a male Indian patient of age 39 having occupation farmer, the residence of a remote village, came to the Mahatma Gandhi Ayurvedic Hospital and Research Centre, outpatient Department of Panchakarma, Salod (H), Wardha, Maharashtra. He was complaining of severe anorexia, the fullness of abdomen, fatigue, nausea and abnormal bowel habit since 20 days, was treated with Trivrutta Churna (operculina turpethum L.) in the dose of 7 gms along with Anupana of Sharkhara 14 gms administered once in the morning for three weeks, was discussed. In a result, significant changes were recorded in the Liver Profile parameters via bilirubin-(total-directindirect), Alanine Transaminase (ALT), Aspartate Aminotransferase (AST) in each visit; along with subjective improvements in the subjective parameters without any adverse effects on safety parameters, i.e. Serum Keratinize, S Cholesterol and Blood sugar were remained within normal limits on the end of treatment. During the hospital stay of 21 days, the patient’s clinical condition was improved day by day. On the 42nd day of study, patients found to be fit without any complaints. Nittya Virechana with Trivrutta Churna was found effective and safe in normalising abnormal LFT in liver disorders.
Published Date: 2021-12-09; Received Date: 2021-11-18